1Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: e mergence of a successful pathogen[J].Clin Microbiol Rev, 2008, 21(3) : 538-582.
2Lin YC, Hsia KC, Chen YC, et al. Genetic basis of multidrug re- sistance in acinetobacter clinical isolates in Taiwan[J].Antimicrob Agents Chemother, 2010,54(5) : 2078-2084.
3Smith MG, Gianoulis TA, Pukatzki S, et al. New insights into Acinetobacer baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis [J]. Genes Dev, 2007,21(5) :601-614.
5Giannouli,Cuccurullo S, Crivaro V, et al. Molecular Epidemiology of multidrug-resistant acinetobacter baumannii in a tertiary care hospital in Naples,Italy,Shows the emergence of a novel epidemic clone[J].J Clin Mierobiol, 2010,48(4) : 1223-1230.
8Glannouli MF,Tomasone A, Agodi H, et al. Molecular epidemiol- ogy of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals[J]. J An- timicrob Chemother, 2009,63 (4) : 828-830.
9Adams MD, Goglin K, Molyneaux N, et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii [J].J Bacteriol,2008,190(24) :8053-8064.
10Bertini AL,Poriel S, Bernabeu D, et aI. Multicopy blaoxa-58 gene as a source of high-level resistance to carbapenems in Acineto- bacter baumannii [J]. Antimicrob Agents Chemother, 2007, 51 (7) :2324-2328.
3Clark NM,Patterson J, Lynch JP 3rd. Antimicrobial resistance among gram-negative organisms in the intensive care unit[J].Curr Opin Crit Care,2003,9(5):413 -423.
4Anstey NM,Currie BJ, Hassell M, et al. Community acquired bac teremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Aeinetobacter baumannii,with carriage in the throat in at-risk groups[J].J Clin Microbiol, 2002,40 (2) : 685- 686.
5Simor AE,Lee M,Vearncombe M,et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit:risk factors for acquisition and management[J].Infect Control Hosp Epidemiol, 2002,23(5) :261-267.
6Vahaboglu H, Coskunkan F, Tansel O, et al. Clinical importance of extended-spectrum β-lactamase (PER 1 type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains[J]. J Med Microbiol, 2001,50 (2):642-645.
7Bou G, Cervero G, Dominguez MA, et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: highlevel carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases[J].J Clin Microbiol, 2000,38 (9) : 3299-3305.
9Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam [J]. Lancet, 1994, 344(8933): 1329-1332.
10Afzal-Shah M, Livermore DM. Worldwide emergence of carbap enem-resistant Acinetobaeter spp [J]. J Antimicrob Chemother, 1998, 41(5): 576 577.
